Secţiunea 1 - INTRODUCERE - Ghid din 2019 privind terapia menopauzei

M.Of. 738 bis

În vigoare

Versiune de la: 10 Septembrie 2019

SECŢIUNEA 1:INTRODUCERE

1.Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B, Citkova R, de Muinck Keizer-Schrama S, Hegervorst E, Jansen E, Liao L, Vlaisavljevic V, Zillikens C, Vermeulen N-European Society for Human R, Embryology Guideline Group on POI. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod 2016; 31:926-937

2.Manson JA, Aragaki AK, Rossouw EJ, Anderson GL, Prentice LR, laCroix ZA, Chlebowski TR, Howard VB, Thomson AC, Margolis L K, Lewis EC, Stefanick LM, Jackson DR, Johnson CK, Martin WL, Shumaker AS, Espeland AM, Wactawski-Wende J, for the WHI - Menopausal hormone therapy and long term all- cause and cause-specific mortality. JAMA. 2017, 318, 927-938doi:10.1001/jama.2017.11217

3.McKinlay MS, Brambilla DJ, Posner JD (1992) - The normal menopause transition. Maturitas 14, 105-15

4.North American Menopause Society (2005) - USA management in menopause. www.menopause.org.

5.World Health Organization Scientific Group. Research on the Menopause in the 1990s. Geneva, Switzerland: World Health Organization; 1996. WHO Technical Report Series 866.

6.Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: Stages of Reproductive Aging Workshop (STRAW) Climacteric. 2001; 4(4):267-272.

7.Avis NE, Crawford SL, Greendale G, Bromberger JT, Evereson Rose AS, Gold BE, Hess R, Joffe H, Kravitz, Tepper GP, Thurston CR, for the Study of Women's Health Across the Nation (SWAN) - Duration of menopausal vasomotorsymptoms over the menopause transition. JAMA Internal Medicine. 2015; 175, . 531-539.

8.Roberts H, Hickey M - Managing the menopause; An update. Maturitas 2016 Apr; 86:53-8.doi:10.1016

9.Freeman EW, Sammel MD, LinH, Liu Z, Gracia CR. Duration of menopausal hot flushes and associated risk factors. Obstet Gynecol. 2011; 117(5):1095-1104.

10.Freeman E, Sammel MD, Sanders RJ. - Risk of long termhot flashes after natural menopause:evidence from the Penn Ovarian Aging Cohort Menopause. 2014; 21, 924-932

11.Slopien R, Wichniak A, Pawlak M, Slopien A, Szymankiewiics A, Sajdak S. Disturbances of sleep continuity in women during the menopausal transition. Pshychiatr Pol. 2015; 49(3):615-23/

12.Baker FC, Lampio L, Saaresranta P, Polo- Kantola P- Sleep and Sleep Disorders in the Menopausal Transition. Sleep Med Clin2018; 13(3):443-456.

13.Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, DubeR, Cote I, Labriee C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J (2009) - Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy..Maturitas., 16(5):907-22

14.Traish MA, Vignozzi L, Simon AJ, Goldstein I, Kim NN (2018) - Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause. Sexual Medicine Reviews. 6(4), 558-571

15.American Cancer Society (2002) - Special Section: Colorectal Cancer and Early Detection. Cancer Facts & Figures

16.Bromberger JT, Schott LL, Kravitz HM, Sowers M, Avis NE, Gold EB, Randolph JF Jr, Matthews KA Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN).Arch Gen Psychiatry 2010; 67(6):598-607.doi:10.1001/archgenpsychiatry.2010.55.

17.Fink G, Sumner B, Rosie R, Wilson H, McQueen J. Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory. Behav Brain Res. 1999; 105(1):53-68.

18.Slopień R, Pluchino N, Warenik- Szymankiewics A, Sajdak S, Luisi M, Drakopoulos P, Genazzani AR - Correlation between allopregnanolone levels and depressive symptoms during late menopausal transition and early postmenopause.Gynecol Endocrinol 2018 Feb; 34(2):144-147.

19.Acs N, Vajo Z, Miklos Zsuzsanna, Paulin F, et al (2000) - Postmenopausal Hormone Replacement Therapy and Cardiovascular Mortality in Central-Eastern Europe The Journals of Gerontology Series A. Biological Sciences and Medical Sciences; 55: M160-M162.

20.Grodstein F, Stampfer MJ, Colditz GA (1997) - Postmenopausal hormone therapy and mortality. N Engl J Med: 336: 1769-1775.

21.Stevenson JC, Flather M, Collins P (2000) - Coronary heart disease in women. N Engl J Med; 343:1891-3.

22.Thurston CR, Sutton- Tyrrell K, Everson-Rose SA, Hess R, Matthews KA (2008) - Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation 2008; 118 (12):1234-40.

23.Wildman RP, Colvin AB, Powell LH, Matthews KA, Everson-Rose SA, Hollenberg S, Johnston JM, Sutton-Tyrrell K (2008). Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN) Menopause. 2008; 15:414-421

24.Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R (2002) - Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002; 39:257-265.

25.Thurston CR, Chang Y, Barinas-Mitchell, Jennings JR, Landssittel DP, Santoro N, von Kanel R, Matthews KA. Menopausal hot flashes and carotid intima media thickness among midlife women. STOKE 2016; 47(12):2910-2915.

26.Thurston CR, Sutton-Tyrell K, Everson-Rose SA, Hess R, Powell LH, Matthews KA. Hot flashes and carotid intima media thickness among midlife women. MENOPAUSE. 2011 Apr; 18(4): 352-8.

27.Ho JE, Mosca L (2002) - Postmenopausal hormone replacement therapy and atherosclerosis. Curr Atheroscler Rep: 2002, 4 (5): 387-95.

28.McCarrey AC, An Y, Kitner-Triolo MH, Ferrucci L, Resnick SM- (2016) - Sex differences in cognitive trajectories in clinically normal older adults. Psychol Aging. 2016; 31(2):166-175

29.Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009; 16:15-23.

30.Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al (2012) - . Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th european stroke conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012; 34:290-296.

31.Lambrinoudaki I, Augoulea A, Armeni E, Rizos D, Alexandrou A, Creatsa M, et al.(2012) - Menopausal symptoms are associated with subclinical atherosclerosis in healthy recently postmenopausal women. Climacteric.; 15:350-357.

32.Hodis HN, Mack WJ. (2011) - A window of opportunity: the reduction of coronary heart disease and total mortality with menopausal therapies is age and time dependent. Brain Res.; 1379:244-252.

33.Salpeter SR, Walsh JME, Greyber E, et al.(2006) - Coronary heart disease events associated with hormone therapy in younger and older women: A meta-analysis. J Gen Intern Med.; 21: 363-366.

34.Salpeter SR, Walsh JME, Greyber E, et al (2004) - Mortality associated with hormone replacement therapy in younger and older women: A meta-analysis. J Gen Intern Med.; 19:791-804.

35.Bainbridge KE, Sowers MF, Crutchfield M, Lin X, Jannausch M, Harlow SD.(2002) - Natural history of bone loss over 6 years among premenopausal and early postmenopausal women. Am. J. Epidemiol.; 156(5), 410-417.

36.Vondracek SF, Hansen LB, McDermott MT- Osteoporosis risk in premenopausal women. Pharmacotherapy 2009; 29(3), 305-317.

37.National Osteoporosis Foundation. What Women Need to Know.National Osteoporosis Foundation, Washington, DC, USA, 2013.

38.CanoA, et al (2017) - Calcium in the Prevention of Postmenopausal Osteoporosis: EMAS Clinical Guide" Maturitas. 2017.doi.org/10.1016/j. 7.10.004.

39.Martinez-Morillo M, Grados D, Holgado S (2012) - Premenopausal osteoporosis: how to treat? Rheumatol. Clin.; 8(2), 93-97.

40.NIH Osteoporosis and Related Bone Diseases National Resource Center. Osteoporosis: Peak Bone Mass in Women. 2012; NIH, Bethesda, MD, USA.

41.Cohen A, Fleischer J, Freeby M, McMahon D, Irani D, Shane E (2009) - . Clinical characteristics and medication use among premenopausal women with osteoporosis and low BMD: the experience of an osteoporosis referral center. J. Womens Health 2009; 18(1), 79-84.

42.McLendon NA, BrockWoodis C-(2014) - A review of osteoporosis management in young premenopausal women.s health. Women's Health, 2014; 13 (3); 59-77.

43.Peris P, Monegal A, Martinez MA, Moll C, Pons F, Guanabens N (2007) - Bone mineral density evolution in young premenopausal women with idiopathic osteoporosis. Clin. Rheumatol. 2007; 26(6), 958-961.

44.Meade TW, Dyer S, Howarth DJ, Imeson JD, Stirling Y (1990) - Antithrombin III and procoagulant activity: sex differences and effects of the menopause. Br J. Haematol:74: 77-81.

45.Winkler UH (1992) - Menopause, hormone replacement therapyand cardiovascular disease: a review of haemostareological findings.Fibrinolysis:6 (suppl 3): 5-10.

46.Godsland FI, Crook D, Stevenson JC, Collins P, Rosano GMC, Lees B, Sidhu M, Poole Wilson PA (1995) - The insulin resistence syndrome in postmenopausal women with cardiological syndrome X. Br.Heart J.:74: 47-52.

47.Godsland FI, Stevenson JC (1995) - Insulin resistence: syndrome or tendency. Lancet: 346: 100-103.

48.Anagnostis P, Christou K, Artzouchaltzi A-M, Paschou SA, Potoupnis M, Tsiridis E, Lambrinoudaki I, Goulis DG (2018) - Early menopause and premature ovarian failure are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis. 54th EASD Annual Meeting of the European Association for the Study of Diabetes, Berlin, Germany, 01-05/10/18; Diabetologia 2018, 61 (Suppl 1):S445.

49.Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, et al(1992) - Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med: 117: 1016-37.

50.North American Menopause Society (2005) - USA management in menopause. www.menopause.org.

51.American Cancer Society (2002) - Special Section: Colorectal Cancer and Early Detection. Cancer Facts & Figures.

52.Lokuge S, Frey BN, Foster JA, Soares CN, Steiner M. (2011) - Depression in women: windows of vulnerability and new insights into the link between estrogen and serotonin. J Clin Psychiatry 2011; 72:e1563-e1569.

53.Yonkers KA, O'Brien PM, Eriksson E (2008) - Premenstrual syndrome. Lancet; 371:1200-1210.

54.Bloch M, Rotenberg N, Koren D, Klein E - (2006) -Risk factors for early postpartum depressive symptoms. Gen Hosp Psychiatry; 28:3-8.

55.Arpels JC (1996) - The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause. A hypothesis and review of supporting data. J Reprod Med 1996; 41:633-639.